Dong Yumei, Dai Yingnan, Wei Guoqian, Cha Li, Li Xueqi
Department of Cardiovascular Medicine, The Fourth Affiliated Hospital of Harbin Medical University No. 37 Yiyuan Street, Nangang District, Harbin 150001, China.
Int J Clin Exp Med. 2014 Nov 15;7(11):4308-15. eCollection 2014.
Previous studies have documented that obstructive sleep apnea (OSA) increases the incidence of hypertension, respiratory failure and unexpected post-operative deaths during night in coronary artery bypass grafting (CABG) patients. We hypothesized that continuous positive airway pressure (CPAP) reduces blood pressure in these patients.
We conducted a prospective, controlled study in 51 patients. The subjects received CPAP treatment were defined as CPAP group, whereas those refused to use CPAP were served as controls. Blood pressure was measured by 24 h ambulatory blood pressure at baseline and at six months.
Fifty-one patients completed the study. CPAP group and controls had similar characteristics. Compared with the control group, the 24-h SBP and 24-h DBP in the CPAP group had a tendency towards lower levels, but the differences were not statistically significant. But the change of SBP in CPAP treatment was significantly higher than controls (CPAP: 10.0 ± 13.5 mm Hg vs.
2.9 ± 10.5 mm Hg, P = 0.040). The rate of hypertension control was improved in the CPAP treatment, but had no statistical difference compared to the controls (CPAP, 76.0% vs. CONTROL, 61.5%; P = 0.260). Compared with controls, the proportion of non-dipping hypertension had a markedly improvement in the CPAP group (CONTROL, 46.2% vs. CPAP, 16.0%; P = 0.034).
CPAP therapy decreased SBP and improved the status of non-dipping hypertension and alleviated daytime somnolence in hypertensive patients with CABG and OSA on standardized antihypertensive treatment. But DBP and hypertension control did not significantly change compared with the control group.
既往研究表明,阻塞性睡眠呼吸暂停(OSA)会增加冠状动脉搭桥术(CABG)患者夜间高血压、呼吸衰竭及意外术后死亡的发生率。我们推测持续气道正压通气(CPAP)可降低这些患者的血压。
我们对51例患者进行了一项前瞻性对照研究。接受CPAP治疗的受试者被定义为CPAP组,而拒绝使用CPAP的患者作为对照组。在基线和6个月时通过24小时动态血压测量血压。
51例患者完成了研究。CPAP组和对照组具有相似的特征。与对照组相比,CPAP组的24小时收缩压(SBP)和24小时舒张压(DBP)有降低的趋势,但差异无统计学意义。但CPAP治疗中SBP的变化显著高于对照组(CPAP:10.0±13.5 mmHg vs.对照组:2.9±10.5 mmHg,P = 0.040)。CPAP治疗中高血压控制率有所提高,但与对照组相比无统计学差异(CPAP,76.0% vs.对照组,61.5%;P = 0.260)。与对照组相比,CPAP组非勺型高血压的比例有明显改善(对照组,46.2% vs. CPAP,16.0%;P = 0.034)。
在接受标准化降压治疗的CABG合并OSA的高血压患者中,CPAP治疗可降低SBP,改善非勺型高血压状态,并减轻日间嗜睡。但与对照组相比,DBP和高血压控制情况无显著变化。